Understanding how Mullerian Inhibiting Substance interacts with its receptors
Structure-function analysis of Mullerian Inhibiting Substance (MIS)
This study is looking at how a hormone called Mullerian Inhibiting Substance (MIS) works in the body, especially in relation to ovarian health, to help improve treatments for women dealing with reproductive issues like Polycystic Ovary Syndrome (PCOS).
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Cincinnati NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-11120861 on NIH RePORTER |
What this research studies
This research investigates the molecular interactions of Mullerian Inhibiting Substance (MIS), a hormone important for female reproductive health. By using advanced techniques like X-ray crystallography and cell-based assays, the study aims to uncover how MIS binds to its receptors, which could lead to better understanding of reproductive disorders. The research focuses on the role of MIS in regulating ovarian function and its implications for conditions such as Polycystic Ovary Syndrome (PCOS). Patients may benefit from insights that could improve fertility treatments and reproductive health management.
Who could benefit from this research
Good fit: Ideal candidates for this research are adult women experiencing reproductive health issues, particularly those with conditions like Polycystic Ovary Syndrome.
Not a fit: Patients who do not have reproductive health concerns or are not of reproductive age may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for reproductive disorders and enhanced fertility management for women.
How similar studies have performed: Previous research has shown promise in understanding the roles of hormones like MIS in reproductive health, indicating that this approach could yield valuable insights.
Where this research is happening
Cincinnati, United States
- University of Cincinnati — Cincinnati, United States (Active)
Researchers
- Principal investigator: Thompson, Thomas B — University of Cincinnati
- Study coordinator: Thompson, Thomas B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.